Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

Gastañaduy, Paul A.;Steenhoff, Andrew P.;Mokomane, Margaret;Esona, Mathew D.;Bowen, Michael D.;Jibril, Haruna;Pernica, Jeffrey M.;Mazhani, Loeto;Smieja, Marek;Tate, Jacqueline E.;Parashar, Umesh D.;Goldfarb, David M.;
clinical infectious diseases 2016 Vol. 62 pp. S161-S167
190
a.2016clinicaleffectiveness

Abstract

Abstract. Background. Botswana introduced monovalent G1P[8] rotavirus vaccine (RV1) in July 2012, providing one of the first opportunities to assess the effect

Keywords

Access

URL:
http://dx.doi.org/10.1093/cid/civ1207

Citation

ID: 120853
Ref Key: a.2016clinicaleffectiveness
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
120853
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store